BSE filing, NSE: DRAGARWQ. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwal's Eye Hospital Ltd: key numbers
- Share price
- ₹5,400.00
- Market cap
- ₹2,538 Cr
- Revenue (annual)
- ₹470.9 Cr
- Net profit (annual)
- ₹70.10 Cr
- P/E (TTM)
- 33.3×Sector 53.7×
- Promoter holding
- 72.67%+0.00% QoQ
- FII holding
- 2.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwal's Eye Hospital Ltd
All →Dr. Agarwal's Eye Hospital Acquisition Worth ₹711.2 Cr
Dr. Agarwal's Eye Hospital Limited has completed its amalgamation with Dr. Agarwal's Health Care Limited, with the transaction valued at ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwal's Eye Hospital Acquisition
Dr. Agarwal's Eye Hospital announced the effectiveness of its Scheme of Amalgamation starting November 01, 2026, and fixed a record date for share allotment.
Dr. Agarwal's Eye Hospital Other Announcement
The company submitted its quarterly shareholding pattern as mandated by SEBI. The filing provides a breakdown of shareholdings among promoters and the public.
Dr. Agarwal's Eye Hospital Acquisition
The NCLT Chennai Bench has sanctioned the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited. The company awaits the order copy.
Dr. Agarwal's Eye Hospital Annual General Meeting
Dr. Agarwal's Eye Hospital Limited held its 32nd Annual General Meeting on September 09, 2026. The meeting concluded with the approval of six business resolutions.
Dr. Agarwal's Eye Hospital Business Update
Dr. Agarwals Eye Hospital inaugurated its new Pinhole Pupilloplasty Centre in Chennai. This facility provides advanced specialized clinical treatments for patients with complex corneal conditions.
Other capital structure change announcements
All →Shree Pushkar Chemicals & Fertilisers Capital Structure Change
Shree Pushkar Chemicals' board approved reissue of forfeited shares and fund raising. Authorised capital rises to 34 million shares, subject to a 2 December 2026 vote.
Lloyds Engineering Works Capital Structure Change
Lloyds Engineering Works will invest Rs 100 Crore in subsidiary Steel Infra Solutions via preferential share subscription. Payment comes in two Rs 50 Crore tranches.
- Value
- ₹100.0 Cr
- Execution
- Whole transaction to complete within 18 months
Ola Electric Mobility Capital Structure Change
Ola Electric allotted equity shares under a rights issue, raising paid-up capital from Rs.4,628.41 Crore to Rs.4,850.57 Crore. Post-allotment shares total 49,98,68,978.
- Value
- ₹222.2 Cr
Ola Electric Mobility Capital Structure Change
Ola Electric allotted 37,02,72,665 partly paid-up rights shares at Rs 16.20 each, about Rs 599.84 Crore on application. Balance call money remains payable.
- Value
- ₹599.8 Cr
Mihika Industries Capital Structure Change
Mihika Industries fixed terms for a ₹90 crore partly paid rights issue. Record date is November 6, 2026, at 9 rights shares per share held.
- Value
- ₹90.00 Cr
Swelect Energy Systems Capital Structure Change
SWELECT approved up to Rs 4.36 crore equity infusion into its wholly owned subsidiary. The funds will develop a 4.5 MWp group captive solar plant in Kerala.
- Value
- ₹4.36 Cr
- Execution
- Multiple tranches per the investee company's offer letter
- solar capacity (DC)
- 4.5 MW